Business
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (&#x...
About this update from Profound Medical Corp
[{"type":"text","content":"Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third QuarterTo release full third quarter 2025 financial results on November 13th; conference call to follow\n\n\n\n TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) --\n \n Profound Medical Corp.\n \n (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today announced preliminary unaudited revenues for the third quarter of 2025. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars.\n \n\n For the quarter ended September 30, 2025, Profound anticipates total revenues to be in the approximate range of $5.2 million to $5.3 million, representing revenue growth of between 84% and 87% over $2.8 million in the same three-month period a year ago. Gross margin is expected to be approximately 72% for the third quarter of 2025, compared to 64% in the prior year period.\n \n\n \"During the third quarter, we achieved new highs in terms of both TULSA-PRO\n \n ®\n \n installed base growth and existing system utilization, driving record total revenues,\" commented Arun Menawat, Profound’s CEO and Chairman. \"Our TULSA-PRO installed base now sits at 67\n \n –\n \n up from 60\n \n –\n \n and, due to our strong and growing capital sales pipeline, we continue to expect to reach at least 75 by the end of the year.”\n \n\n These figures are preliminary and unaudited, and actual revenues may differ. The Company plans to announce its full third quarter 2025 financial results after market close on Thursday, November 13, 2025. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.\n \n\n\n Third Quarter 2025 Results Conference Call Details\n \n :\n \n\n Date: Thursday, November 13, 2025\n \n\n Time: 4:30 p.m. ET\n \n\n Live Call Registration:\n \n https://register-conf.media-server.com/register/BI1d4819ae421e47ff95ddb48cba2afcea\n \n\n\n The call will also be broadcast live and archived on the Company's website at\n \n www.profoundmedical.com\n \n under \"News & Events\" in the Investors section.\n \n\n\n About Profound Medical Corp.\n \n\n\n ...